Just last night, I was complaining to a friend: “Institutions wouldn’t touch a coin like Injective.”

Then I checked this morning—and Nasdaq had approved Canary’s staked $INJ ETF, ticker INJC. The price shot up.

The announcement was crystal clear: at least 90% of the fund’s assets will be staked, with the rewards going to holders.

In other words, Wall Street can soon get spot exposure and earn staking rewards—all through a brokerage account.

They talk like they’re not interested, but they move faster than anyone.